scispace - formally typeset
M

Masaharu Miyajima

Researcher at University of Utah

Publications -  19
Citations -  330

Masaharu Miyajima is an academic researcher from University of Utah. The author has contributed to research in topics: Granulation & Polymerization. The author has an hindex of 11, co-authored 19 publications receiving 321 citations.

Papers
More filters
Journal ArticleDOI

Dissolution Mechanism of Diclofenac Sodium from Wax Matrix Granules

TL;DR: The results suggest that proper selection of rate-controlling agents based on their physicochemical properties (such as swelling ability and solubility) is important in designing WMGs with desired dissolution profiles.
Journal ArticleDOI

A New Attempt To Solve the Scale-Up Problem for Granulation Using Response Surface Methodology

TL;DR: A computerized optimizing technique based on a response surface methodology was developed to study the scale-up problem in the manufacturing of granules, and it was found that a universal optimal formulation unaffected by manufacturing scale could be obtained by minimizing the integrated optimization function.
Journal ArticleDOI

Simultaneous Optimization of Wet Granulation Process Involving Factor of Drug Content Dependency on Granule Size

TL;DR: Computer optimization technique applied to the simultaneous optimization of wet granulation process by a high-speed mixer granulator suggested that computer optimization would benefit the wet granulations process even if drug content segregation was involved in the process.
Journal ArticleDOI

An application of the computer optimization technique to wet granulation process involving explosive growth of particles

TL;DR: In this paper, a computer optimization technique based on well-designed experiments is applied to optimize the wet granulation process in which an explosive growth of particles is involved, and a universal optimal condition unaffected by manufacturing scale is obtained by the minimization of T(X).
Journal ArticleDOI

Control of drug concentration-time profiles in vivo by zero-order transdermal delivery systems

TL;DR: Control of 9-β-arabinofuranosyladenine and ara-A-2',3'-diacetate concentrations in blood from zero-order transdermal delivery systems was achieved using newly designed transder mal patches with rate-limiting membranes using copolymer compositions chosen according to the hydration properties of the membrane.